文献速递哮喘

全基因组测序在哮喘儿童中识别出CRISPLD2为肺功能基因

Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma.
PubMed 文献 · Chest · 2019-09-23

该研究对哥斯达黎加1053名哮喘家系个体进行全基因组测序,发现CRISPLD2基因单核苷酸多态性rs12051168与基线FEV1/FVC比值在全基因组水平显著相关,并在三个独立队列中通过meta分析重复验证,提示结合气道高反应性可识别遗传更均一的哮喘亚组。

要点

  • CRISPLD2 rs12051168与哮喘患者基线FEV1/FVC在全基因组水平显著相关。
  • 该关联在三个独立队列中重复验证,但仅限于有气道高反应性信息的队列。
  • 利用气道高反应性等特征可识别遗传更均一的哮喘亚组。

核心结论

  • CRISPLD2可能是合并气道高反应性的哮喘个体基线肺功能的重要基因。

研究设计与样本

  • 研究对来自哥斯达黎加哮喘遗传流行病学研究的三人家系和扩展家系共1053名个体进行全基因组测序。
  • 哮喘状态由医生诊断定义,大多数哮喘参与者对乙酰甲胆碱有气道高反应性。
  • 采用基于家系的单变异关联检验评估与肺功能表型的关联。

主要发现

  • 基线FEV1/FVC比值与CRISPLD2的rs12051168在全基因组水平显著相关,未调整模型P=3.6×10-8,协变量调整模型P=5.6×10-6。
  • rs12051168与基线FEV1(P=3.3×10-3)、支气管舒张后FEV1(P=7.3×10-3)和支气管舒张后FEV1/FVC比值(P=2.7×10-3)名义相关。
  • 该关联在三个独立队列中meta分析重复验证(合并加权z评分P=.015),但仅限于有气道高反应性信息的队列。

临床怎么用

  • 对于哮喘儿童,可关注CRISPLD2 rs12051168等遗传变异与基线肺功能的关联,尤其当合并气道高反应性时。
  • 临床识别哮喘亚组时可考虑结合气道高反应性等特征,以提高遗传关联研究的可重复性。

局限性

  • 研究基于哥斯达黎加家系人群,结果外推至其他人群需谨慎。
  • 关联在无气道高反应性信息的队列中未重复验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Asthma is a common respiratory disorder with a highly heterogeneous nature that remains poorly understood. The objective was to use whole genome sequencing (WGS) data to identify regions of common genetic variation contributing to lung function in individuals with a diagnosis of asthma. METHODS: WGS data were generated for 1,053 individuals from trios and extended pedigrees participating in the family-based Genetic Epidemiology of Asthma in Costa Rica study. Asthma affection status was defined through a physician's diagnosis of asthma, and most participants with asthma also had airway hyperresponsiveness (AHR) to methacholine. Family-based association tests for single variants were performed to assess the associations with lung function phenotypes. RESULTS: A genome-wide significant association was identified between baseline FEV1/FVC ratio and a single-nucleotide polymorphism in the top hit cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2) (rs12051168; P = 3.6 × 10-8 in the unadjusted model) that retained suggestive significance in the covariate-adjusted model (P = 5.6 × 10-6). Rs12051168 was also nominally associated with other related phenotypes: baseline FEV1 (P = 3.3 × 10-3), postbronchodilator (PB) FEV1 (7.3 × 10-3), and PB FEV1/FVC ratio (P = 2.7 × 10-3). The identified baseline FEV1/FVC ratio and rs12051168 association was meta-analyzed and replicated in three independent cohorts in which most participants with asthma also had confirmed AHR (combined weighted z-score P = .015) but not in cohorts without information about AHR. CONCLUSIONS: These findings suggest that using specific asthma characteristics, such as AHR, can help identify more genetically homogeneous asthma subgroups with genotype-phenotype associations that may not be observed in all children with asthma. CRISPLD2 also may be important for baseline lung function in individuals with asthma who also may have AHR.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Kachroo P, Hecker J, Chawes BL, et al. Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma. Chest. 2019. PMID: 31557467. doi:10.1016/j.chest.2019.08.2202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。